Home › NDC Lookup › Ingredients › Coal Tar › 68093-5206-01
MG217 Psoriasis Therapeutic Scalp Treatment Coal Tar .03 g/g Shampoo — NDC 68093-5206-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

MG217 Psoriasis Therapeutic Scalp Treatment Coal Tar .03 g/g Shampoo — NDC 68093-5206-1 (Billing 68093-5206-01)

by Wisconsin Pharmacal Company · 1 BOTTLE in 1 CARTON / 120 g in 1 BOTTLE

This is a package of MG217 Psoriasis Therapeutic Scalp Treatment Coal Tar .03 g/g Shampoo from Wisconsin Pharmacal Company, marketed since Jul 2014 and currently FDA-listed. It is this product's only package size.

NDC 68093-5206-01
🏷️ FDA NDC (as labeled) 68093-5206-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 68093-5206-1 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
68093 labeler · 5206 product · 1 package
Package marketed since
Jul 1, 2014
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC)
0012277052064
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 68093-5206-1
Product NDC 68093-5206
11-digit billing NDC 68093520601
RxCUI 205100
UNII R533ESO2EC
UPC 0012277052064
Application # part358H
SPL Set ID 6d3f4685-eb47-445e-86fb-3601d2c110e7
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH FINAL
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2014-07-01
Route TOPICAL
Dosage form SHAMPOO
Substance COAL TAR
Quick answers
  • RxCUI (RxNorm): 205100
Why two NDCs? The FDA registers this code as 68093-5206-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 68093-5206-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It relieves the itching, scaling, flaking and redness of psoriasis, seborrheic dermatitis and dandruff. Which of these a product treats depends on the brand, so check your package....
  • It depends on the product. Most coal tar shampoos say to use them at least twice a week, leaving the lather on for several minutes. Some ointments, gels and lotions can be used one...
  • Be careful. Coal tar can make you more likely to sunburn for up to 24 hours after you apply it. Cover up and limit sun exposure during that time.
  • Don't combine it with light therapy or prescription psoriasis medicines unless your doctor says it's okay. Check with me or your doctor first if you're not sure.
📖 Read our full Coal Tar guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
68093-5206-01 You're viewing this Main listing 1 BOTTLE in 1 CARTON / 120 g in 1 BOTTLE 2014-07-01 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
MG217 Psoriasis Therapeutic Scalp Treatment .03 g/gthis 68093-5206-01 Wisconsin 1 bottle — — FDA listed —
MG217 Psoriasis Medicated Conditioning .03 g/g 68093-7232-01 Wisconsin 1 bottle — — FDA listed —
MG217 Psoriasis Medicated multi-symptom .03 g/g 68093-7233-01 Wisconsin 1 jar — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2014
On the market since
Jul 2014
📍
2026
Currently FDA-listed
12 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Coal Tar inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerWisconsin Pharmacal Company
FDA applicationpart358H (OTC MONOGRAPH FINAL)
Labeler code68093
First marketedJul 2014
Product typeHuman Otc Drug
Portfolio16 products on file

More NDCs from Wisconsin Pharmacal Company labeler code 68093

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 25 words ▾

Uses For the temporary relief of these symptoms associated with psoriasis, seborrheic dermatitis or dandruff itching scaling flaking redness irritation ofthe scalp. Helps prevent recurrence.

⏱️ Dosage and Administration 39 words ▾

Directions shake well before using. wet hair then massage liberal amount of MG217 into the scalp and leave on for several minutes. Rinse thoroughly. for best results, use at least twice a week or as directed by a physician.

⚠️ Warnings 154 words ▾

Warnings For external use only. Ask doctor before use if condition covers a large area of the body. When using this product avoid contact with the eyes.

If contact occurs, rinse eyes thoroughly with water. use caution in exposing skin to sunlight. It may increase your tendency to sunburn for up to 24 hours after application. do not use with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs unless directed by a physician. do not use for prolonged periods without consulting a physician. Stop use and ask a doctor if condition worsens. condition does not improve after regular use of this product as directed.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately. WARNING This product can gose you to chemicals including Coal Tar, which is known to the State of California to cause cancer.

For more information go to www.P65Warnings.ca.gov

🧪 Active Ingredient 14 words ▾

Drug Facts Active Ingredient Coal Tar 3% (from Coal Tar Topical Solution, USP 20%)

🧪 Inactive Ingredients 36 words ▾

Inactive ingredients Deionized water, Sodium Alkyl Ether Sulfate, Cocamidopropyl Betaine, Lauramidopropyl Hydroxysultaine, Palmitic Betaine, Guar Hydroxypropyltrimonium Chloride, Hydrolyzed Collagen, Phenoxyethanol, Methyl Paraben, n-Butyl Paraben, Ethyl Paraben, Isobutyl Paraben, Propyl Paraben, Fragrance FD and C No. 1

🎯 Purpose 6 words ▾

Purpose Psoriasis, Seborrheic Dermatitis, Dandruff Treatment

📄 Ask a Doctor Before Use If 13 words ▾

Ask doctor before use if condition covers a large area of the body.

📄 When Using This Product 69 words ▾

When using this product avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water. use caution in exposing skin to sunlight. It may increase your tendency to sunburn for up to 24 hours after application. do not use with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs unless directed by a physician. do not use for prolonged periods without consulting a physician.

📄 Stop Use and Ask a Doctor If 21 words ▾

Stop use and ask a doctor if condition worsens. condition does not improve after regular use of this product as directed.

📄 Keep Out of Reach of Children 18 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

📄 Other Information 28 words ▾

WARNING This product can gose you to chemicals including Coal Tar, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov

📄 Questions or Comments 2 words ▾

Questions? 1-800-635-3696

📄 Package Label / Principal Display Panel 2 words ▾

carton label'

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for MG217 Psoriasis Therapeutic Scalp Treatment (this brand).

Top reported reactions

Psoriasis420
Malaise300
Fatigue267
Pain252
Nasopharyngitis236
Skin Exfoliation227
Fall223

Reporter sex

0 reports

Serious outcomes

Disabling132
Death13
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 113 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Final". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Wisconsin Pharmacal Company. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Wisconsin Pharmacal Company is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 68093-5106-01 · Wisconsin 68093-7106-01 · Wisconsin →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.